Back to Companies
Larimar Therapeutics, Inc.
LRMRNasdaqCIK: 0001374690
Recent Form 4 activity at Larimar Therapeutics, Inc. (LRMR) spans 12 filings across 9 insiders (all of them on the buy side). Purchases total $55.2M against $0 in sales — heavily weighted toward buying, for a net purchase of $55.2M. Flynn James E (Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $30.0M by Flynn James E. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$60.2M
Purchases
$55.2M
Sales
$0
Unique Insiders
9
Recent Insider Trades
12 loaded
| Jul 8 | LRMR Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Insider | Buy | $166.9K |
| May 20 | LRMR Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Insider | Award | $183.6K |
| May 20 | LRMR Larimar Therapeutics, Inc. | LEFF JONATHAN S | Insider | Award | $183.6K |
| May 20 | LRMR Larimar Therapeutics, Inc. | Flynn James E | Director, 10% Owner | Award | $183.6K |
| May 20 | LRMR Larimar Therapeutics, Inc. | Truitt Joseph | Insider | Award | $183.6K |
| May 20 | LRMR Larimar Therapeutics, Inc. | THOMAS FRANK E | Insider | Award | $183.6K |
| Mar 2 | LRMR Larimar Therapeutics, Inc. | Flynn James E | Director, 10% Owner | Buy | $25.0M |
| Jan 27 | LRMR Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | Insider | Grant | $2.2M |
| Jan 27 | LRMR Larimar Therapeutics, Inc. | Celano Michael | Insider | Grant | $812.2K |
| Jan 27 | LRMR Larimar Therapeutics, Inc. | Clayton Russell | Insider | Grant | $553.8K |
| Jan 27 | LRMR Larimar Therapeutics, Inc. | Shankar Gopi | Insider | Grant | $553.8K |
| Aug 4 | LRMR Larimar Therapeutics, Inc. | Flynn James E | Director, 10% Owner | Buy | $30.0M |
12 filings